Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Swiss Advanced Vision (SAV-IOL) has announced the launch of Project R-TASC, set to disrupt the global intraocular lens (IOL) market. Cataracts are responsible ...
LensGen, a California-based developer of intraocular lenses (IOL) for the treatment of presbyopia and cataracts, has announced the release of $11 million in Series A funding. The funds are part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results